nimodipine has been researched along with Palsy in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study is to determine the effects of ischemia in the spinal cord when a calcium channel blocker, nimodipine, is administered intravenously before, during, and after crossclamping of the thoracic aorta." | 3.68 | Spinal cord protection with intravenous nimodipine. A functional and morphologic evaluation. ( Bennink, GB; Cooley, DA; Langford, LA; Schittek, A, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schittek, A | 1 |
| Bennink, GB | 1 |
| Cooley, DA | 1 |
| Langford, LA | 1 |
| Keppel Hesselink, JM | 1 |
2 other studies available for nimodipine and Palsy
| Article | Year |
|---|---|
Spinal cord protection with intravenous nimodipine. A functional and morphologic evaluation.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cerebrospinal Fluid Pressure; Constriction; Heart Rate; In | 1992 |
[The administration of calcium channel blockers in patients with cerebrovascular diseases].
Topics: Cerebrovascular Disorders; Humans; Nimodipine; Paralysis | 1989 |